Mass Spectrometry and Compound Identity

Start with the ion, not just the molecular weight

Mass spectrometers measure ions by mass-to-charge ratio, written m/z. Electrospray ionisation can give a peptide several charges, so one compound may produce several signals at different m/z values. Comparing each of those numbers directly with a neutral molecular mass would be misleading. The charge assignment has to be understood first. [A6]

Here is an invented example using a neutral mass of 1,200 Da and rounding each added proton’s mass to 1 Da for illustration. These are approximate teaching numbers, not exact-mass acceptance criteria.

All three rows can describe the same neutral mass. The laboratory should state whether it reports an observed ion, a calculated neutral mass or a deconvoluted mass, and whether the theoretical comparison uses monoisotopic or average mass. A different convention is not, by itself, evidence of a different compound. [A6]

Define the expected material before comparing numbers

The comparison needs an explicit identity: sequence where relevant, terminal groups, modifications and chemical form. A short product name may leave some of those details unresolved. The product specification guide identifies the fields to check.

Keep bulk composition and ion assignment separate. If a report assigns a protonated peptide ion, that assignment alone does not establish the amount or identity of every counter-ion in the supplied solid. Ask which species the reported mass represents rather than assuming it includes the full salt composition. See salt forms and counter-ions.

Variant names also need care. The CJC-1295 DAC and no-DAC comparison illustrates why the material’s structural description must be resolved before choosing a theoretical comparison. That is an identity question, not a reason to borrow a mass value from a similarly named item.

Why matching mass does not establish sequence order

Consider the hypothetical sequences Ala–Glu–Asp–Gly and Gly–Ala–Asp–Glu, with identical terminal groups and residue stereochemistry. They contain the same residues in different orders. Their intact masses are the same, although their sequences differ. This is a composition example, not a claim that these are interchangeable materials.

Peptide isomers, including sequence inversions and leucine/isoleucine variants, cannot be distinguished by m/z alone. Tandem MS can add sequence information through fragmentation, but mixed precursors can produce composite spectra. Creese and colleagues demonstrated this problem in a defined peptide-library study and examined additional ion-mobility separation. [A7]

For a report reader, the useful distinction is whether the evidence is intact-mass compatibility or includes an appropriate structural investigation. Do not silently upgrade the first into complete sequence confirmation. Likewise, an ordinary intact-mass match does not resolve L/D stereochemistry. The methods must be capable of addressing the particular ambiguity. [A7]

Read the comparison and its limits together

A numerical match without a stated comparison criterion leaves the decision difficult to assess. A discrepancy also needs investigation rather than automatic rejection or an improvised explanation. Ask the reporting laboratory to reconcile the ion assignment, expected form and result.

What MS does not replace

An identity-focused spectrum does not itself establish a quantitative content assay. Quantitative MS methods exist, but they require a method designed for that purpose; the heading “MS” is not enough. Identity, purity and quantitative tests have different performance requirements. [A2]

Read identity, purity and assay together, and keep purity and identity separate when interpreting an accompanying chromatogram. The testing methods guide places MS alongside other measurements. The quality documentation hub explains how to check which evidence is available for the lot offered.